Inventor
Fuqiang Ruan
Inventor
Bellevue, WA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
C07DHeterocyclic compounds22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07CAcyclic or carbocyclic compounds17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07BGeneral methods of organic chemistry4%
C08BPolysaccharides4%
C07KPeptides1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,442,799Heterocyclic compounds and uses thereof201910,336,756(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta20199,637,488'Heterocyclic compounds as inhibitors of class I PI3KS'20179,562,113'Labeled alginate conjugates for molecular imaging applications'20179,260,399'Labeled alginate conjugates for molecular imaging applications'20169,149,477'5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta'20158,993,583'5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta'20158,980,901'5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta'20158,974,766'Labeled alginate conjugates for molecular imaging applications'20158,779,131'6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta'20148,680,151'Compounds, compositions and methods for treating or preventing hypoxic or ischemic injury'2014RE044638'Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta'20138,586,597'6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta'2013RE044599'Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta'20138,207,153'Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta'20128,202,997'Compositions and methods for treating or preventing hypoxic or ischemic injury'20127,932,260'Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta'20116,031,135'Trimethylsphingosine derivatives'20005,663,404'Sphingosine-1-phosphate essentially free of L-threo isomer'19975,391,800'Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2000Based in Seattle, WA, US· patent location history
2011–2019Patents assigned to ICOS CORP (10)· patent assignee history
2011–2019Based in Bellevue, WA, US· patent location history
2012–2019Patents assigned to RUAN FUQIANG (6)· patent assignee history
2012–2013Patents assigned to FOWLER KERRY W (2)· patent assignee history
2012–2013Patents assigned to HUANG DANWEN (2)· patent assignee history
2015–2017Patents assigned to BELLEROPHON BCM LLC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ICOS CORP | 10 | 2011–2019 |
| RUAN FUQIANGself | 6 | 2012–2019 |
| BELLEROPHON BCM LLC | 3 | 2015–2017 |
| FOWLER KERRY W | 2 | 2012–2013 |
| HUANG DANWEN | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Bellevue, Washington, US | 17 | 2011–2019 |
| Seattle, Washington, US | 3 | 1995–2000 |